(2S,3S)-2-(3,4-dihydroxyphenyl)-3-methyl-3,4-dihydro-2H-chromene-5,7-diol

Details

Top
Internal ID c42dcd6b-837d-4bf6-b29b-1f25696fd335
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Hydroxyflavonoids > 7-hydroxyflavonoids
IUPAC Name (2S,3S)-2-(3,4-dihydroxyphenyl)-3-methyl-3,4-dihydro-2H-chromene-5,7-diol
SMILES (Canonical) CC1CC2=C(C=C(C=C2OC1C3=CC(=C(C=C3)O)O)O)O
SMILES (Isomeric) C[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O
InChI InChI=1S/C16H16O5/c1-8-4-11-13(19)6-10(17)7-15(11)21-16(8)9-2-3-12(18)14(20)5-9/h2-3,5-8,16-20H,4H2,1H3/t8-,16-/m0/s1
InChI Key WTOWZADSSKQQQE-PWJLMRLQSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C16H16O5
Molecular Weight 288.29 g/mol
Exact Mass 288.09977361 g/mol
Topological Polar Surface Area (TPSA) 90.20 Ų
XlogP 1.80
Atomic LogP (AlogP) 2.82
H-Bond Acceptor 5
H-Bond Donor 4
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S,3S)-2-(3,4-dihydroxyphenyl)-3-methyl-3,4-dihydro-2H-chromene-5,7-diol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8933 89.33%
Caco-2 - 0.6255 62.55%
Blood Brain Barrier - 0.7250 72.50%
Human oral bioavailability - 0.8000 80.00%
Subcellular localzation Mitochondria 0.5280 52.80%
OATP2B1 inhibitior - 0.5823 58.23%
OATP1B1 inhibitior + 0.9197 91.97%
OATP1B3 inhibitior + 0.9760 97.60%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior - 0.9315 93.15%
P-glycoprotein inhibitior - 0.9423 94.23%
P-glycoprotein substrate - 0.9394 93.94%
CYP3A4 substrate - 0.5318 53.18%
CYP2C9 substrate - 0.5963 59.63%
CYP2D6 substrate + 0.4743 47.43%
CYP3A4 inhibition - 0.7156 71.56%
CYP2C9 inhibition - 0.7484 74.84%
CYP2C19 inhibition - 0.7921 79.21%
CYP2D6 inhibition - 0.9256 92.56%
CYP1A2 inhibition + 0.7834 78.34%
CYP2C8 inhibition + 0.4918 49.18%
CYP inhibitory promiscuity - 0.5372 53.72%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6189 61.89%
Eye corrosion - 0.9857 98.57%
Eye irritation + 0.6670 66.70%
Skin irritation - 0.6104 61.04%
Skin corrosion - 0.8460 84.60%
Ames mutagenesis + 0.5600 56.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6580 65.80%
Micronuclear + 0.7400 74.00%
Hepatotoxicity - 0.7375 73.75%
skin sensitisation - 0.7916 79.16%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity + 0.7556 75.56%
Mitochondrial toxicity + 0.5750 57.50%
Nephrotoxicity - 0.6894 68.94%
Acute Oral Toxicity (c) III 0.3898 38.98%
Estrogen receptor binding - 0.5485 54.85%
Androgen receptor binding + 0.6716 67.16%
Thyroid receptor binding + 0.7268 72.68%
Glucocorticoid receptor binding + 0.7429 74.29%
Aromatase binding + 0.6731 67.31%
PPAR gamma + 0.6537 65.37%
Honey bee toxicity - 0.9052 90.52%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity + 0.6100 61.00%
Fish aquatic toxicity + 0.9477 94.77%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1951 P21397 Monoamine oxidase A 99.31% 91.49%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.98% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.00% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.41% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.40% 95.56%
CHEMBL1806 P11388 DNA topoisomerase II alpha 86.44% 89.00%
CHEMBL2581 P07339 Cathepsin D 86.33% 98.95%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 86.04% 93.40%
CHEMBL1293249 Q13887 Kruppel-like factor 5 85.15% 86.33%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 83.52% 99.15%
CHEMBL1929 P47989 Xanthine dehydrogenase 81.90% 96.12%
CHEMBL4208 P20618 Proteasome component C5 81.30% 90.00%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 81.26% 94.80%
CHEMBL2535 P11166 Glucose transporter 80.32% 98.75%

Cross-Links

Top
PubChem 44445800
NPASS NPC238254